Fresno at Bristol-Myers Squibb

Los Angeles, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

Ability to lead a team of motivated sales professionals by creating and articulating a vision for the district aligned with organizational objectives
Skill in effectively analyzing performance data, market trends, market access dynamics, and building strategic business plans to address challenges and opportunities
Clear and thorough understanding of BMS Hematology products, the Hematology marketplace, relevant competitive products, and the disease area
Ability to leverage knowledge to model and coach team to exemplary selling skills and product/disease state knowledge
Capacity to actively facilitate the growth and development of team members based on their needs, motivation, and business requirements
Ability to create an environment of continuous learning where team members feel challenged and engaged
Proficiency in leading a group through change while maintaining focus on current and future business needs
Compliance with relevant standards (incomplete in description)

Responsibilities

Lead a team of highly motivated sales professionals representing the integrity of the company by providing approved, disease, and product information/resources to key decision makers and stakeholders
Inspire and motivate the team to reach and exceed business goals while maximizing their growth and development potential
Report to the Regional Business Director and collaborate across a matrix sales organization to address customer needs, deliver on sales targets, and demonstrate value to customers
Analyze performance data, market trends, and market access dynamics to build strategic business plans
Demonstrate understanding of BMS Hematology products, marketplace, competitors, and disease area; coach team accordingly
Facilitate team members' growth and development
Foster an environment of continuous learning and engagement
Lead the team through change while focusing on business needs

Skills

Oncology Sales

Hematology Sales

Pharmaceutical Sales

Sales Management

Immunotherapy

Cancer Therapies

District Management

Account Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free